Showing results (31-40 of 74) with videos related to
Sort By:
Pageof 8
Hepatology (Baltimore, Md.)|December 25, 2016
Reduction in liver transplant wait-listing in the era of direct-acting antiviral therapyJennifer A Flemming, W Ray Kim, Carol L Brosgart, et al.Hepatology (Baltimore, Md.)|March 21, 2022
Association between social determinants of health and rates of liver transplantation in individuals with cirrhosisJennifer A Flemming, Hala Muaddi, Maja Djerboua, et al.Annals of Surgical Oncology|September 22, 2021
Predictors of Postoperative Liver Decompensation Events After Resection in Patients with Cirrhosis and Hepatocellular Carcinoma: A Population-Based StudyZuhaib M Mir, Maya Djerboua, Sulaiman Nanji, et al.Canadian Journal of Gastroenterology & Hepatology|March 21, 2022
Rising Healthcare Costs and Utilization among Young Adults with Cirrhosis in Ontario: A Population-Based StudyJeffrey B Ames, Maya Djerboua, Norah A Terrault, et al.Hepatology (Baltimore, Md.)|June 26, 2021
NAFLD and Alcohol-Associated Liver Disease Will Be Responsible for Almost All New Diagnoses of Cirrhosis in Canada by 2040Jennifer A Flemming, Maya Djerboua, Patti A Groome, et al.AIDS (London, England)|March 25, 2026
HIV-sex interaction effect on risk of hepatitis C-related cirrhosis, decompensation, and hepatocellular carcinomaWilliam J McFarlane, Susan B Brogly, Jennifer A Flemming, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|February 1, 2026
Real-world outcomes in patients with cirrhosis undergoing cholecystectomy: a population-based studySulaiman Nanji, Sean Bennett, Zuhaib M Mir, et al.Cellular Immunology|August 28, 2004
Disruption of membrane cholesterol stimulates MyD88-dependent NF-kappaB activation in immature B cellsJennifer A Flemming, Kristin H Perkins, Lia Luus, et al.Cancer|July 22, 2014
Risk prediction of hepatocellular carcinoma in patients with cirrhosis: the ADRESS-HCC risk modelJennifer A Flemming, Ju Dong Yang, Eric Vittinghoff, et al.Canadian Liver Journal|August 22, 2022
Transjugular intrahepatic portosystemic shunt for the treatment of refractory ascites: A population-based cohort studyJeffrey M Mah, Maya Djerboua, Patti A Groome, et al.Pageof 8